Perrigo Animal Health, a global healthcare supplier, and Piedmont Animal Health, a companion animal veterinary pharmaceutical company, announced a partnership to bring companion animal drugs to the market. Piedmont will develop and gain regulatory approval; Perrigo will commercialize and distribute the products via its global network.
Piedmont already has several new drug applications and generic drugs in development. Perrigo manufactures PetArmor and Sentry flea and tick preventives brands, as well as Petrodex enzymatic toothpaste brand.
“Perrigo delivers high-quality pet health products to consumers through its portfolio of leading brands such as PetArmor, Sentry, and Petrodex,” said Neal Wilmore, vice president and general manager of Perrigo Animal Health, a division of Perrigo Co. plc in Dublin. “We are committed to accelerating category sales by increasing retailer and consumer access to new and innovative products. The strategic partnership with Piedmont Animal Health is another example of our efforts to invest in and deliver new products to consumers searching for vet-quality solutions with the convenience and affordability of a retail purchase.”
“Piedmont has been one of the most successful pharmaceutical companies in the industry in developing and gaining regulatory approval for animal health products,” said Roland Johnson, CEO of Greensboro, N.C.-based Piedmont. “We recognize that various products fit different channels, so we have recently expanded our third- party work accordingly. Perrigo has a strategic vision that aligns with our own as well as an experienced commercial team to exploit novel product opportunities.”